JPMORGAN CHASE & CO - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 76 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,092
+67588.9%
20,087
+74296.3%
0.00%
Q2 2023$9270.0%0.00%
Q1 2023$0270.0%0.00%
Q4 2022$0270.0%0.00%
Q3 2022$0270.0%0.00%
Q2 2022$0
-100.0%
27
-99.9%
0.00%
Q1 2022$29,000
-39.6%
20,782
-1.4%
0.00%
Q4 2021$48,000
-71.9%
21,079
-48.6%
0.00%
Q3 2021$171,000
+111.1%
40,992
+141.3%
0.00%
Q2 2021$81,000
+3950.0%
16,991
+6950.2%
0.00%
Q1 2021$2,000241
+3342.9%
0.00%
Q3 2020$070.0%0.00%
Q2 2020$07
-88.9%
0.00%
Q3 2019$0630.00%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 360,000$1,710,0000.88%
APIS CAPITAL ADVISORS, LLC 120,000$570,0000.49%
Parkman Healthcare Partners LLC 415,384$1,973,0000.43%
Altium Capital Management LP 172,218$818,0000.19%
Vigilare Wealth Management 52,535$250,0000.15%
BRIGHTON JONES LLC 332,875$1,581,0000.08%
Ikarian Capital, LLC 200,204$950,0000.08%
IPG Investment Advisors LLC 31,106$147,754,0000.04%
DOWLING & YAHNKE LLC 150,464$715,0000.04%
Jump Financial, LLC 58,225$276,0000.03%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders